Aflibercept

Details

Files

Generic Name:

Aflibercept

Project Status:

Complete

Therapeutic Area:

Macular edema, diabetic

Manufacturer:

Bayer Inc.

Call for patient/clinician input open:

August 19, 2014

Brand Name:

Eylea

Project Line:

Reimbursement Review

Project Number:

SR0396-000

Call for patient/clinician input closed:

October 8, 2014

NOC Status at Filing:

Pre NOC

Performance Metric:

Not achieved

Submission Type:

Initial

Indications:

Macular edema, diabetic

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

May 7, 2015

Files

Submission Status Report View PDF

Clinical Report View PDF

Pharmacoeconomic Report View PDF

Recommendation and Reasons View PDF

Patient Group Input Submissions View PDF

Last Updated : September 16, 2014